COMPANY REGISTRATION NUMBER: 5373700 CHARITY REGISTRATION NUMBER: 1113267 CERVICAL SPINE RESEARCH SOCIEfY (EUROPEAN SEcfIoN) Company Limited by Guarantee UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors Lifford Hall Lifford Lane Kings Norton Birmingham B30 3JN
CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2023 Pase Trustees, annual report (incorporating the director's report) Independent examiner's report to the trustees Statement of financial activities (including income and expenditure account) Statement of financial position Note5 to the financial statements The following pase does not form part of the financial 8tatement8 Detailed statement of finaiicial activities 12
Page I CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE TRUSTEES, ANNUAL REPORT (INCORPORATING THE DIRECTOR'S REPORT) YEAR ENDED 31 DECEMBER 2023 The trustees, who are also the directors for the purposes of company law, present their report and the unaudited financial statements of the charity for the year ended 31 December 2023. Referen¢e and administrative details Reglstered charity name Cervical Spine Research Society (European Section) Charity regi8tration number 1113267 Company registration number 5373700 Prlnclpal office and registered Lifford Hall office Lifford Lane Kings Norton Birniinsham B30 3JN The trustees Dr P Bancel Dr A Combalia A Leonard Dr A I Geleway Independent examlner K S Chambers Lrfbrd Hall Lifford Lane Kings Norton Birmingham B30 3JN Structure* govemance and management The society was incorporated as a company liniited by guarantee on 23 February 2005 (company number 5373700) and obtained charitable status on 14 March 2006 (charity number 1113267). The accounts are presented in Euros. Legal status The charity is a limited company by guarantee. In the event of the company being wound up, the liabklity in respect of the guarantee is limited to £1 per member.
Page 2 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE TRUSTEES, ANNUAL REPORT (INCORPORATING THE DIRECTOR'S REPORT) (¢fftitiiiued) YEAR ENDED 31 DECEMBER 2023 Objectives and activities The Q5R&Europe strongly contributes to the academic evaluation on cause and epidemiology of pathologist of the cervical spine and the development, feasibility, and effectiveness of treatments of cervical spine disorders. The CSR&F.urope aims to provide a networking platform for scientists at their meetings, active participation in international congresses and c105e engagement with their sister societies. Achievements and perfomance The trustees are aware of the need to indemnify and monitor risk, As the charity's work expands, a review of risks associated WAth the expansion will be implemented with a view to mitigate any risks identified. For the year ended 2023, the annual general meeting was held in Stockholm, Sweden Ist-2nd June 2023. The profit made from this conference was donated to the Society. There were two instructional cadaver dissection course.s ht,Icl in Barcelona during 2023. The S(Kiety plans two new additional educational 'hands on, cadavL)ric dissection courses in 2024 - Salzburg, Austria in February 2024 and Lyon, France in SeptembLJr 2024, Financial review The charity's income increased during 2023 to Q42 662. but with expenditure totalling a45,752, the result is a net reduction in reserves of ,090 for the year. Reserves The trustees continue to aim to build up reserves to a level that will perniit the sustained funding of projects, training fellowships and ongoing education by means of instructional and hands-on surgical courses. The appropriatic)Ji of reserves and the leveI at which the trustees consider them necvssary will be re-appraised c)ii an annual basis and will be dependent upon the projects to be undertaken. Small company provi8ions lliis report has been prepared in accordance with the provisions applicable to companie5 entitled to the small c panies exemption. The trus trustee al report was app ved on 22 May 2024 and signed on behalf of the board 0£ Director
Page 3 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SEcfioN) COMPANY LIMITED BY GUARANTEE INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SEcfIoN) YEAR ENDED 31 DECEMBER 2023 I report to the trustees on my examination of the financial statements of CeTvical Spine Research Society (European Section) ('the charity,) for the year ended 31 December 2023. Responslbilities and bast8 of report A5 the truytees of the company (and also its directors for the PUTPOSes of company law) you are responsible for the prepaTation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 ACY). Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report An respect of my examination of the charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 ACY). In carryin8 Out my examination I have followed the Directions given by the Charity Commi55ion under section 145(5)(b) of the 2011 Act. Independent examiner's gtatement- matter of concern identlfied I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act,. or the financial statsments do not accord with those records; or the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair, view which is not a niatter considered as part of an independent examination. or the financial statements have not been prepared in accordance with the methods and principles of the Staternent of Recomrnendcd Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. K S Chambers Independent Examiner Lifford Hall Lifford Lane Kings Norton Birmingham B3Q 3JN 22 May 2024
Page 4 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE STATEMENT OF FINANCIAL AcfIvITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT) YEAR ENDED 31 DECEMBER 2023 2023 Unrestricted funds Total fund6 Total funds 2022 Note Income and endowments Voluntary income Total income 142,662 142,662 69,317 142,662 142,662 69,317 Expendlture Expenditure on charitable activities TotaI expendlture 145,752 145,752 90,863 145,752 145,752 90.863 Net expenditure and net movement in funds (3,090) (3,090) (21,546) Reconclliation of funds Total funds brought forward TotaI funds ¢arried forward 211,458 211,458 233,004 208,368 208,368 211,458 The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. All movements are in Unrestricted Funds. The charity has no recognised gain5 or 105ses other than the re5ts for the period as set out above. All of the activities of the charity are classed as continuing. The notes on pages 6 to 11 form part of these financial statements.
Page 5 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMED BY GUARANTEE STATEMENT OF FINANCIAL POSITION 31 DECEMBER 2023 2023 2022 Note Fixed assets TangibIe fixed assets 12 365 457 Current assets Debtors Cash at bank and in hand 13 9,777 210,714 219,894 219,894 220,491 Creditors.. amounts falling due within one year Accruals and deferred income 11,891 9,490 Net cuent assets 208,003 211,001 Total assets legs current liabilitie8 208.368 211,458 Net agset8 208,368 211,458 Funds of the charlty Unrestricted funds 208,368 211,458 Total charity funds 14 208,368 211,458 For the year ending 31 December 2023 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors, responsibilities: The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476; The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements. These financial statements have been prepared in accordance with the provisions applicable to companies b]'ect to the small compani ' regime. ncial 24, tements were ap d are signed on be oved by the board of trustees and authorised for issue on f of the board by: 22Ma Director The notes on pages 6 to 11 form part of these finanoiaI statements.
Page 6 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SEcfIoN) COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2023 General information The charity is a public benefit entity and a private company limited by guarantee, TegisteTed in England and Wales and a registered charity in England and Wales. The address of the registered office 15 Lifford Hall. Lifford Iane, Kings Norton, Birmingham, B30 3JN. Statement of compliance These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporttng Standard applicable in the UK and the Republic of Ireland,, the Statement of Recommended Practice applicable to charities preparing theAr accounts in accordance with the Financial Reporting Standard applicable in the UK and RepubEic of Ireland (fRS 102) (Charities SORP (FRS 102)) and the Companies Art 2006, Accounting policies Basis of preparation The financlal statements have been prepared under the historical cost convention and in accordance with the Statement of Recommended Practice "Accountin8 and Reporting by Charities (SORP {FRS102)) and the Companies Art 2011. The accounts have been pPared ancl are presentsd in Euros. Going concern There are no material uncertaintses about the charity's ability to continue. Cash flow statement The trustees have taken advantage of the exemption from including a cash flow statement in the financial statements on the grounds that the charity is small. Judgements and key sources of estimation uncertainty The preparation of the financial statements requires management to make judgements, estimates and assumpti()ns that affKt the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Forei currencies Assets and liabilitie5 in foreign currenaes are translated into Euros at the rates of exchange ruling at the balance sheet date. Transactions in foreign cwrencies are translated into Euros at the rate of exchange ruling at the date of transaction. Exchange difference5 are taken into account in arriving at the operating profit. Fund accounting Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purpose5. Designated funds are unrestricted funds earniarked by the trustees for parttcular future project or commiiment.
Page 7 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS I¢oNtiiiNetl) YEAR ENDED 31 DECEMBER 2023 Accounting policies (comtiiiitsd) Fund a¢counting (¢oiitiiiMed) Restricted funds are subjected to restrictions on their expenditure decIared by the donor or through the terms of an appeal, and fall into one of two subolasses: restricted income funds or endowment funds. Incoming resour¢e8 All income is included in the statement of financiaE activities when entitlement has passed to the charity, it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific poIicies are appEied to particular categories of income: . income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably. - income from contracts for the supply of services is recognlsed with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted. Regource8 expended Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any V AT which cannot be fully recovered, and is classified under headings of the state.ment of financial activities to which it relates.. expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities. other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities. All costs are aIlocated to expenditure categories reflecting thc use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are appurtioned between the activities they contribute to on a reasonable, justifiable and consistent basis. Tangible assets Tangible a$ts are initially recorded at C05t, and subsequently stated at cost less any accumuEatcd depreciation and impaRrment losses. Any tangible a55ets carried at revalued amounts are recorded at the fair value at the date of revaluation less any Subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities. decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses, except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activÉties.
Page 8 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENfs IcoNtiiiueA) YEAR ENDED 31 DECEMBER 2023 A¢countlng poIicieg (¢oAtlrtued) Depreciation Depreciation is calculated so as to write off the c05t or valuation of an asset, Less its residual value, over the useful economic life of that asset as follows: Equipment 20% reducing balance Impairment of fixed a88ets review for indicators of impairnient is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purpose5 of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash- generating unit to which the asset belon85. The cash-generating unit is the smallest idenfifiable group of assets that includes the asset and generates cash inAows that largely independent of the cash infiows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabiIities of the charity are assigned to those units. Financial Instruments A financial asset or a fin8cial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic flnancial instruments are initially recognised at the amount receivable or payable including any related transaction costs, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest foT a similar debt instrument. Llmited by guarantee The charity is a ]imited company by guarantee. In the event of the company beKng wound up, the liability in respect of the guarantee is limited to £1 per member.
Page 9 CERVICAL SPINE RESEARCH SOCIETY {EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (cmitiiiued) YEAR ENDED 31 DECEMBER 2023 Voluntary income Unrestricted Total Funds Unrestricted Total Funds Funds 2023 Funds 2022 Donations Donations and sponsorship Course sponsorship and delegate contributions 86,5n 86,571 46,916 46,916 56,091 56,091 22,400 22,400 Other donatlons and legacies Bank interest 142.662 142,662 69,317 69,317 Expenditure on charltable actlvitles by fund type Unrestricted TotaI Funds Unrestricted Total Funds Funds 2023 Funds 2022 Educational course5 Support costs 106,454 39,298 106,454 39,298 50,522 40,341 50,522 40,341 145,752 145,752 90,863 90,863 Expenditure on charitable activities by activity type Activities undertaken directly Support Total funds Total fund costs 2023 2022 Educational courses 106A54 39,298 145,752 9063 Analysis of Support costs Support costs Total 2023 Total 2022 Finance costs Accountancy & Bookkeeping Professional fees Depreciation SecretariaI expenses 1,744 3,370 18,443 91 15.650 1,744 3J70 18,443 91 15,650 IA20 7,165 6,015 114 25,725 39,298 39,298 40,439
Page 10 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMrrED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (¢0 YEAR ENDED 31 DECEMBER 2023 Net expenditure Net expenditure i5 Stated after chazging/(crediting): 2023 2022 Depreciation of tan8ible fixed assets Foreign exchange differences 92 1,196 114 1,303 10. Independent examination fees 2023 2022 Fees payable to the independent examiner for: Independent examination of the finaiicial statements 16,1% 12,946 11. Trustee8 and executive committee members The trustees and executive committee members have received no remuneration during the year for trustee duties. Expenses in respect of travel costs only in attending instructional courses as lecturers and meetin85 requiring presidentKal representation have been reimbursed to certain trustees and executive committee members amountin8 to f16,392 (2022: f13,754). Payments have been made to A Leonard of £15,650 (2022: f25,627) in respect of secretarial and administration work carried out. 12. Tangible fixed assets Equipment C08t At l January 2023 and 31 December 2023 Depre¢lation At l January 2023 Charge for the year At 31 December 2023 1,239 782 92 874 Carrying amount At 31 December 2023 365 At 31 December 2022 457
Page 11 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SEcfioN) COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS IcoAtiniied) YEAR ENDED 31 DECEMBER 2023 13. Debtors 2023 2022 Prepayments and accrued income 9,777 14. Analysis of charitable funds UnreBtrlcted funds At 31 December 2023 At l January 2023 Income Expenditure General funds 211,458 142,662 (145,752) 208,368 At 31 December 2022 At l january 2022 Income Expenditure General funds 233,004 69,317 (90,863) 211,458 15. Analysis of net a88ets between funds Unrestricted Total Funds Fund5 2023 Taiigible fixed assets Current assets Creditors less than l year Net assets 365 219,894 (11,891) 208,368 365 219,894 (IIB91) 208,368 Unrestricted Total Funds Funds 2022 Tangible fixed assets Current assets Creditors less than l year Net assets 457 220,491 (9,490) 211A58 457 220,491 (9,490) 211,458